From tumor size and HER2 status to systems oncology for very early breast cancer treatment
| dc.contributor.author | Roukos, D. H. | en |
| dc.contributor.author | Ziogas, D. | en |
| dc.date.accessioned | 2015-11-24T19:15:17Z | |
| dc.date.available | 2015-11-24T19:15:17Z | |
| dc.identifier.issn | 1744-8328 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21489 | |
| dc.rights | Default Licence | - |
| dc.subject | Antibodies, Monoclonal/therapeutic use | en |
| dc.subject | Antibodies, Monoclonal, Humanized | en |
| dc.subject | Breast Neoplasms/*drug therapy/metabolism/pathology | en |
| dc.subject | Decision Making | en |
| dc.subject | Drug Resistance, Neoplasm | en |
| dc.subject | Female | en |
| dc.subject | Humans | en |
| dc.subject | Neoplastic Stem Cells | en |
| dc.subject | Receptor, erbB-2/*metabolism | en |
| dc.subject | Retrospective Studies | en |
| dc.title | From tumor size and HER2 status to systems oncology for very early breast cancer treatment | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.primary | 10.1586/era.09.177 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/20131987 | - |
| heal.identifier.secondary | http://www.expert-reviews.com/doi/pdfplus/10.1586/era.09.177 | - |
| heal.journalName | Expert Rev Anticancer Ther | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2010 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.74 KB
- Format:
- Item-specific license agreed upon to submission
- Description: